High Acceptability of an Orally Dispersible Tablet Formulation by Children
1
Department of Pharmaceutical Sciences, Division of Pharmaceutical Technology, University of Basel, 4056 Basel, Switzerland
2
Pediatric Pharmacology and Pharmacometrics, University Children’s Hospital (UKBB), University Hospital Basel, 4056 Basel, Switzerland
*
Author to whom correspondence should be addressed.
Academic Editor: Karel Allegaert
Children 2021, 8(3), 194; https://doi.org/10.3390/children8030194
Received: 3 February 2021
/
Revised: 3 March 2021
/
Accepted: 3 March 2021
/
Published: 5 March 2021
There is a high unmet medical need for child-appropriate oral dosage forms. The acceptability of a novel placebo orally dispersible tablet formulation (pODT) was therefore evaluated. Monolithic tablets contain an inorganic calcium carbonate/calcium phosphate carrier material as the main excipient. They were assessed in a cross-sectional acceptability study. The 40 child participants were between 2 to 5 years and 6 to 10 years old. One pODT with 5 mm diameter was administered to each participating child by placement on the tongue or into the buccal cavity. Parents were asked to complete a questionnaire together with the study personnel. The spontaneous reactions of the children were recorded. The ease of administration and children’s acceptance of the tablet was rated by research staff on a 4-point acceptability scale and by parents on a 5-point Likert scale. The older subjects answered how they had liked the pODT by pointing to the appropriate face of a Facial Hedonic Scale. pODT had very high acceptability as 93% of parents, and all questioned children reported the formulation to be acceptable or very acceptable. Staff reported administering pODT in these children without problems. None of the children showed distress on receipt of pODT. We conclude that the proposed child-friendly dosage form provides a convenient option for oral drug administration and is expected to enhance drug-adherence in pediatric patients.
View Full-Text
Keywords:
oral drug administration; clinical trial; children; orally dispersible tablets; palatability
▼
Show Figures
Graphical abstract
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
MDPI and ACS Style
Wagner-Hattler, L.; Kiene, K.; Bielicki, J.; Pfister, M.; Puchkov, M.; Huwyler, J. High Acceptability of an Orally Dispersible Tablet Formulation by Children. Children 2021, 8, 194. https://doi.org/10.3390/children8030194
AMA Style
Wagner-Hattler L, Kiene K, Bielicki J, Pfister M, Puchkov M, Huwyler J. High Acceptability of an Orally Dispersible Tablet Formulation by Children. Children. 2021; 8(3):194. https://doi.org/10.3390/children8030194
Chicago/Turabian StyleWagner-Hattler, Leonie, Klara Kiene, Julia Bielicki, Marc Pfister, Maxim Puchkov, and Jörg Huwyler. 2021. "High Acceptability of an Orally Dispersible Tablet Formulation by Children" Children 8, no. 3: 194. https://doi.org/10.3390/children8030194
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
